glp-1 compounders Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Compounded GLP-1s: Why doctors worry

Want to hear more from an expert

In a six-month clinical trial, a GLP-1 drug called liraglutide was shown to slow the progression of the disease and improve the cerebral metabolic rate of glucose (CMRglc), which is a measurement of glucose metabolism in the brain important for normal cognitive function

With the new 7.2mg dose, 1 in 3 patients have been shown to lose up to 25% of their starting weight The Wegovy injection was also found, on average, to reduce: The numbers from these studies are from people taking Wegovy alongside a diet and exercise plan

Instead of stopping entirely, they reduce to the lowest effective dose and maintain it long-term